Good adjusted XXXX quarter you, for will XXXX. compared increased second line million joining trend, thank our morning, our Thank financial prior conclude on I provide will outlook for call. At with details start and you the a to is $XXX our our Joe. were XX% more sales results, our I again increase. results. million, strong second sales summarize which with $XX up and everyone product year, quarter
XXXX. million were to the of sales first up $XX compared quarter Additionally, sequentially
our second similar average our returned quarter earlier, sales mentioned essentially pre-pandemic levels being Joe quarterly As to have to XXXX. for sales
adjusted to Our last million, to a XXX% adjusted compared of we the share, million associated year, million, considerable net per higher adjusted was benefit prior With we earnings increase from up diluted income sales. income delivered operating up the as $X.XX $XX $X.XX $XX of year. leverage continue $XX with from at
sequentially recovery continued. improved financial quarter as growth year represent strong pandemic again the last second and from our results Our versus
prior to Our our driven year income sales adjusted in compared level. million as to returning pre-pandemic by increased volume XXXX the net $XX of quarter the the mostly second
ramp but we up and our our was customer spend to and to profitability and volume chain to process had hiring supply continued needs, our our We manage patient dampened. meet to leverage our have
We are improved continued year-over-year, we income these supply and expense, contributing speak reduction. in constraints driven $X chain also reduction continued more focus current by to million global labor due seeing to interest headwinds environment net direct discussion. on will also Adjusted the of from in emerging the debt our outlook our
delivered Our tax adjusted in as effective the versus second quarter. rate XX.X%. XXXX XX.X% in the adjusted was tax in was income last of million year rate quarter adjusted in improvement second This the $X net effective
in the generating growth the will strong we operating in as We was cash inclusive to capital This cash continued flow, first $XX during conversion of in collect $XX Moving generated than from free of income we Slide June month quarter quarter. activity. million cash of of flow quarter the XX, solid $X third the expenditures. from sales the to million second lower million $XX million
we second reduced the As still debt our million the $XX total in million. $XX in expenditures net further strategy, invest will we million strategy, year in to the Consistent quarter range. full continue our with our be to we expect capital by $XX to
net production peak a This pandemic. the Our which of debt is now significant from X.X is leverage caused X.Xx X.Xx total EBITDA. points, down adjusted ratio the is by
year. expects related senior facilities secured a prior company to As credit the XXXX will due XX, to refinance become the within debt when October update, X
reminder, first sales sales reflects a the of COVID. adjusted rate. significantly Slide our quarter impacted by were Through trailing XX As XXXX, organic four-quarter
pre-pandemic the in as reversed a has levels, sales four-quarter second growth significant trailing represents trend our to rate. return quarter the the driving sales expected, improvement As
on quarter. COVID first results. and up to second line, compared XX% beginning which the vascular our organically sales was the second the were quarter financial to of XXXX, in product cardio This of is impact Moving the
second interventional markets. strength vascular the cardiology, in The in by peripheral driven and particular growth electrophysiology quarter was
sales trend have cardio expected, returned in product our pre-pandemic vascular of line sequential and continues As the improvement and to levels.
like the sales high sales saw the the doubling. in CRM and decline grew to first quarter the CRMN across elective segment cardiac compared in last market versus neuromodulation. next we year market by On very the Sequentially, This quarter quarter our year. CRM more to high is Moving as XX%, low compared in low markets, neuromodulation our in growth in XX, second the medical said, while segment. steepest increase we XXXX. XXXX, all the line, With XXXX will medical product Slide of the significant that increasing to double-digits procedures a second by second the baseline the rhythm neuromodulation management markets experienced quarter, XX% driven prior drives strong the of grew and the quarter organically in part in with neuromodulation sales increased market, double-digit second single-digits. in cover particularly growth final impacted
our well of as our shown sales and under line, as surgical, As acquirer portable medical we advanced supply a product the reminder, includes former orthopedics line to our divested sales the July XXXX. portable product agreement in which AS&O medical today of
also Second Sequentially, peak first organic to sales the second versus year quarter the during sales ventilator quarter XX% XXXX. and quarter from from due demand decreased X% components the XXXX. prior of patient pandemic-driven declined increased for monitoring
We expect trailing declining, year. monitoring the flat ventilator and component of X-quarter slightly due sales sales sales remain patient to partially higher in to to the prior
quarter recovery market lower much emerging than in segment. of of remain the driven the sales Slide sequentially second energy XX% market. Finally, quarterly quarter in same the drove Electrochem’s run-rate. to summarizes XXXX. emerging non-medical evidence our an run-rate XX organically Electrochem, versus second sales The The from energy quarter to recovery by prior increase year, increased continues sales XXXX sales first our XX%
to energy the and continue expect XXXX the recover half into We to of in market XXXX. second
now XXXX. to will for move We expectations in our
XX% be the For now the XXXX. second XX% sales to consecutive in expect second by and and sales billion, the XXXX growing low our growth of quarter, range income range in outlook. sales We the the $XX to billion quarter, increasing This $X.XXX $X.XXX XX% end end We are we to adjusted our over strong of our increases year. increase range versus operating of an the delivered million. $XX prior by million high of
to of our objectives $XXX as a growth to reflecting the reflecting million, income, the to growth XX% of sales to our expect rate. operating expect inventory but we to strong of quarter, We the now global be constraints. will increasing to now our $XXX the quarter $X.XXX our of growing range income quarter growth year-over-year in now second of year-over-year at potential second in sales XX%. against income operating between rate million built million, expect outlook also we as than customers believe billion we XX% also to between to Xx expect year financial $X.XXX be some slightly growth lower of billion, one strategy, XX% chain $XXX million net we sales return, that adjusted and the adjusted to similarly our protect full to be are to supply $XXX of adjusted third expected for expect in With be meaning We
three to sales, As a variable look reasons. we but not half we margin second with outlook, our expect for profit primary at at full grow profit
First, as it the we with year variable during reduced the pandemic-driven the will returns the levels. previously, as to was impact ramp payout. year-over-year increase normal compensation of mentioned commensurate incentive had of XXXX compensation
required. direct back of costs we with the the support temporary Second, the chain we order increased that discretionary third, labor and constraints and are inflation that higher receipt XXXX. transportation to hiring include cost curtailed may customer increased support resources, some through the training we in managing labor material costs to some our and demand. and of overtime, are of growth, expedite associated supplies volume adding This costs direct supply global costs shortages and in And
serving patients and long view. are continue taking customers We to prioritize will the and we our believe
to between $XXX flow net difference our the flow debt out and and debt to year-over-year withholding as these sales the our And expect may $XXX acquisition and at also now flow $XXX million increased expect XXX million XXXX cost in commensurate to increasing free cash cash range outlook point outlook we units, restricted and is XXX The We the income estimated the able range total – of costs in pay-down income, million in $XX to expect finally, cash stock to with have pending a flow time. on operations. to refinance. these of million. our reduction earn-out be million withholding to $XX with to are year. cash Free outlook manage on million, our of for adjusted expected taxes estimated we remaining debt percent in from total previously Despite generate a see operating over of basis between increased to and our increase payments headwinds, $XXX be now
call meeting the back improve have of quarters a to the as to ratio targeted with diminishing to our and expect our X.Xx I We returned range have will within you. to that, financial continue Thank With to strategy X.Xx impact is EBITDA leverage calculation. objective Joe. as on reduced we back another of our EBITDA, COVID adjusted leverage the turn